138 related articles for article (PubMed ID: 25218824)
1. Hsa-miR-1246, hsa-miR-320a and hsa-miR-196b-5p inhibitors can reduce the cytotoxicity of Ebola virus glycoprotein in vitro.
Sheng M; Zhong Y; Chen Y; Du J; Ju X; Zhao C; Zhang G; Zhang L; Liu K; Yang N; Xie P; Li D; Zhang MQ; Jiang C
Sci China Life Sci; 2014 Oct; 57(10):959-72. PubMed ID: 25218824
[TBL] [Abstract][Full Text] [Related]
2. Expression of microRNA in human retinal pigment epithelial cells following infection with Zaire ebolavirus.
Oliver GF; Orang AV; Appukuttan B; Marri S; Michael MZ; Marsh GA; Smith JR
BMC Res Notes; 2019 Oct; 12(1):639. PubMed ID: 31570108
[TBL] [Abstract][Full Text] [Related]
3. Ebola virus glycoprotein directly triggers T lymphocyte death despite of the lack of infection.
Iampietro M; Younan P; Nishida A; Dutta M; Lubaki NM; Santos RI; Koup RA; Katze MG; Bukreyev A
PLoS Pathog; 2017 May; 13(5):e1006397. PubMed ID: 28542576
[TBL] [Abstract][Full Text] [Related]
4. A Rapid Screen for Host-Encoded miRNAs with Inhibitory Effects against Ebola Virus Using a Transcription- and Replication-Competent Virus-Like Particle System.
Wang Z; Li J; Fu Y; Zhao Z; Zhang C; Li N; Li J; Cheng H; Jin X; Lu B; Guo Z; Qian J; Liu L
Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29772717
[TBL] [Abstract][Full Text] [Related]
5. Virus-encoded miRNAs in Ebola virus disease.
Duy J; Honko AN; Altamura LA; Bixler SL; Wollen-Roberts S; Wauquier N; O'Hearn A; Mucker EM; Johnson JC; Shamblin JD; Zelko J; Botto MA; Bangura J; Coomber M; Pitt ML; Gonzalez JP; Schoepp RJ; Goff AJ; Minogue TD
Sci Rep; 2018 Apr; 8(1):6480. PubMed ID: 29691416
[TBL] [Abstract][Full Text] [Related]
6. Involvement of viral envelope GP2 in Ebola virus entry into cells expressing the macrophage galactose-type C-type lectin.
Usami K; Matsuno K; Igarashi M; Denda-Nagai K; Takada A; Irimura T
Biochem Biophys Res Commun; 2011 Apr; 407(1):74-8. PubMed ID: 21362405
[TBL] [Abstract][Full Text] [Related]
7. Development of a cAdVax-based bivalent ebola virus vaccine that induces immune responses against both the Sudan and Zaire species of Ebola virus.
Wang D; Raja NU; Trubey CM; Juompan LY; Luo M; Woraratanadharm J; Deitz SB; Yu H; Swain BM; Moore KM; Pratt WD; Hart MK; Dong JY
J Virol; 2006 Mar; 80(6):2738-46. PubMed ID: 16501083
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of hsa-miR-6086 protects human umbilical vein endothelial cells against TNFα-induced proliferation inhibition and apoptosis via CDH5.
Cai X; Zhou X; Xiao F; Ye B; Huang W; Huang Z
Gene; 2018 Jun; 661():202-208. PubMed ID: 29605606
[TBL] [Abstract][Full Text] [Related]
9. Chemically Modified Human Serum Albumin Potently Blocks Entry of Ebola Pseudoviruses and Viruslike Particles.
Li H; Yu F; Xia S; Yu Y; Wang Q; Lv M; Wang Y; Jiang S; Lu L
Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28167539
[TBL] [Abstract][Full Text] [Related]
10. Dynamic changes of circulating miRNAs induced by the Ebola virus vaccine VSV-EBOV.
Fischer T; Spohn M; Olearo F; Zinser ME; Kasonta R; Stubbe HC; Rechtien A; Ly ML; Schmiedel S; Lohse AW; Grundhoff A; ; Addo MM; Dahlke C
Vaccine; 2018 Nov; 36(46):7083-7094. PubMed ID: 30244872
[TBL] [Abstract][Full Text] [Related]
11. Identification of Ebola virus microRNAs and their putative pathological function.
Liang H; Zhou Z; Zhang S; Zen K; Chen X; Zhang C
Sci China Life Sci; 2014 Oct; 57(10):973-81. PubMed ID: 25266153
[TBL] [Abstract][Full Text] [Related]
12. Regulation of the MIR155 host gene in physiological and pathological processes.
Elton TS; Selemon H; Elton SM; Parinandi NL
Gene; 2013 Dec; 532(1):1-12. PubMed ID: 23246696
[TBL] [Abstract][Full Text] [Related]
13. Ebola virus glycoprotein toxicity is mediated by a dynamin-dependent protein-trafficking pathway.
Sullivan NJ; Peterson M; Yang ZY; Kong WP; Duckers H; Nabel E; Nabel GJ
J Virol; 2005 Jan; 79(1):547-53. PubMed ID: 15596847
[TBL] [Abstract][Full Text] [Related]
14. Cell-cell contact promotes Ebola virus GP-mediated infection.
Miao C; Li M; Zheng YM; Cohen FS; Liu SL
Virology; 2016 Jan; 488():202-15. PubMed ID: 26655238
[TBL] [Abstract][Full Text] [Related]
15. Genome-Wide Search for Competing Endogenous RNAs Responsible for the Effects Induced by Ebola Virus Replication and Transcription Using a trVLP System.
Wang ZY; Guo ZD; Li JM; Zhao ZZ; Fu YY; Zhang CM; Zhang Y; Liu LN; Qian J; Liu LN
Front Cell Infect Microbiol; 2017; 7():479. PubMed ID: 29209594
[TBL] [Abstract][Full Text] [Related]
16. Pathogenesis of Ebola hemorrhagic fever in primate models: evidence that hemorrhage is not a direct effect of virus-induced cytolysis of endothelial cells.
Geisbert TW; Young HA; Jahrling PB; Davis KJ; Larsen T; Kagan E; Hensley LE
Am J Pathol; 2003 Dec; 163(6):2371-82. PubMed ID: 14633609
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA 299-3p modulates replicative senescence in endothelial cells.
Jong HL; Mustafa MR; Vanhoutte PM; AbuBakar S; Wong PF
Physiol Genomics; 2013 Apr; 45(7):256-67. PubMed ID: 23362143
[TBL] [Abstract][Full Text] [Related]
18. Microarray analysis of differentially expressed microRNAs in allergic rhinitis.
Shaoqing Y; Ruxin Z; Guojun L; Zhiqiang Y; Hua H; Shudong Y; Jie Z
Am J Rhinol Allergy; 2011; 25(6):e242-6. PubMed ID: 22185732
[TBL] [Abstract][Full Text] [Related]
19. Functional mutations in spike glycoprotein of Zaire ebolavirus associated with an increase in infection efficiency.
Ueda MT; Kurosaki Y; Izumi T; Nakano Y; Oloniniyi OK; Yasuda J; Koyanagi Y; Sato K; Nakagawa S
Genes Cells; 2017 Feb; 22(2):148-159. PubMed ID: 28084671
[TBL] [Abstract][Full Text] [Related]
20. Ebola Virus Encodes Two microRNAs in Huh7-Infected Cells.
Diallo I; Husseini Z; Guellal S; Vion E; Ho J; Kozak RA; Kobinger GP; Provost P
Int J Mol Sci; 2022 May; 23(9):. PubMed ID: 35563619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
